Keflex (Cephalexin) for Soft Tissue Skin Abscess
Incision and drainage is the primary treatment for skin abscesses, and antibiotics including Keflex are generally unnecessary after adequate drainage unless specific high-risk features are present. 1, 2
Primary Treatment Approach
The most important intervention for a skin abscess is incision and drainage—antibiotics alone are insufficient and should not replace surgical drainage. 1, 3
- For simple, uncomplicated abscesses after adequate drainage, antibiotics are not recommended. 1, 2
- Studies demonstrate that placebo achieves 90.5% cure rates after drainage of MRSA abscesses, compared to 84.1% with cephalexin, showing no significant benefit from antibiotics. 4
- The single published trial specifically examining antibiotics for surgical site infections found no clinical benefit when drainage was adequate. 1
When Antibiotics ARE Indicated After Drainage
Antibiotics should be added to drainage in the following situations:
- Systemic signs of infection: Temperature >38°C or <36°C, heart rate >90-110 beats/minute, respiratory rate >24 breaths/minute, or WBC >12,000 or <4,000 cells/μL. 1, 2
- Extensive surrounding cellulitis: Erythema and induration extending >5 cm from the abscess margin. 1, 2
- Immunocompromised patients: Including diabetes, HIV, chronic corticosteroid use, or other immunosuppressive conditions. 1, 2
- Location-specific concerns: Abscesses near the axilla or perineum require broader coverage including anaerobes (cephalexin is inadequate). 2, 3
- Failed drainage or inability to achieve adequate drainage. 2
Cephalexin Dosing and Selection
When antibiotics are indicated and MRSA is NOT suspected, cephalexin 500 mg orally four times daily for 5-7 days is appropriate. 2, 5, 3
- Cephalexin provides excellent coverage for methicillin-susceptible Staphylococcus aureus (MSSA) and streptococci, the most common pathogens in simple skin abscesses. 3, 6
- Clinical cure rates exceed 95% with cephalexin for uncomplicated soft tissue infections when appropriate pathogens are present. 6, 7
- The WHO elevated cephalexin to first-choice status in 2021 for mild skin and soft tissue infections due to appropriate spectrum and tolerability. 3
Critical Limitation: MRSA
Cephalexin has NO activity against MRSA and should NOT be used when community-acquired MRSA is suspected or confirmed. 3, 8
When to Suspect MRSA and Avoid Cephalexin:
- Previous MRSA infection or colonization. 2, 3
- High local MRSA prevalence (>10-30% in your community). 3
- Purulent drainage with surrounding cellulitis. 5
- Recent hospitalization or healthcare exposure. 3
- Injection drug use. 3
- Close contact with someone with MRSA. 3
Alternative Antibiotics for MRSA Coverage:
- Oral options: Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily, doxycycline 100 mg twice daily, or clindamycin 300-450 mg four times daily. 2, 5, 3
- IV options (for severe infections): Vancomycin 15 mg/kg every 12 hours, daptomycin, linezolid, or ceftaroline. 2, 5, 3
Important Clinical Nuance
A landmark pediatric study found no difference between cephalexin and clindamycin for treating uncomplicated SSTIs despite 69% MRSA prevalence, with 94-97% cure rates in both arms when drainage was performed. 8 This suggests that adequate drainage with close follow-up may be more important than initial antibiotic choice for uncomplicated abscesses, even in MRSA-prevalent areas. 8
However, this does not mean cephalexin is appropriate for MRSA—rather, it emphasizes that drainage is paramount and antibiotics may be unnecessary altogether for simple abscesses. 8, 4
Duration and Monitoring
- Treatment duration: 5-7 days for most uncomplicated cases after adequate drainage. 2, 5
- Reassess within 48-72 hours to ensure clinical improvement. 2, 5
- Extend treatment only if infection has not improved within this timeframe. 2
- Obtain cultures during drainage to guide targeted therapy if patient fails to improve. 2
Common Pitfalls to Avoid
- Never treat abscesses with antibiotics alone without drainage—this is the most common error and leads to treatment failure. 1, 3
- Do not use cephalexin for necrotizing infections—these require urgent surgical debridement plus broad-spectrum IV antibiotics (vancomycin plus piperacillin-tazobactam or a carbapenem). 1, 5, 3
- Do not use cephalexin for animal or human bites—these require amoxicillin-clavulanate for anaerobic coverage. 5, 3
- Do not fail to obtain cultures before starting antibiotics—this prevents targeted therapy if empiric treatment fails. 2, 3
- Do not assume beta-lactams are always appropriate—local MRSA epidemiology must guide empiric choices. 3, 4